Data compiled by Redley Lamar · ChainSifter Intelligence
3Suppliers
2Customers
2Debt Items
0Related Chains
Source-Backed Evidence Depth
Turn Therapeutics Inc. (TTRX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
8Total relationships
2Distinct source URLs
6High confidence
0.818Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Turn Therapeutics Inc. Suppliers
Ticker
Name
Confidence
Evidence
MEDLINE
MEDLINE
90%
The Medline Agreement establishes a multi-year framework for supply and co-development activities, including manufacturing scale-up for our PermaFusion-based formulations
ONE-VENDOR
ONE-VENDOR
90%
The majority of our accounts payable and accrued expenses are concentrated with one vendor having a balance of approximately $ 1.2 million which represents approximately 53 % of our accounts payable …
SCAPA
SCAPA
80%
For medical device applications of GX-03, including GX-03 impregnated gauze, we utilize in-house sterilization services provided by SCAPA via gamma irradiation (GAMMA)
Turn Therapeutics Inc. Customers
Ticker
Name
Confidence
Evidence
GEM-GLOBAL-YIELD-LLC
GEM-GLOBAL-YIELD-LLC
62%
nd funds from the investor. Amortization of deferred offering cost was approximately $0.50 million and $0 for the years ended December 31, 2025 and 2024, respectively. An $0.85 million deferred offer…
GEM-YIELD-BAHAMAS-LIMITED
GEM-YIELD-BAHAMAS-LIMITED
62%
nd funds from the investor. Amortization of deferred offering cost was approximately $0.50 million and $0 for the years ended December 31, 2025 and 2024, respectively. An $0.85 million deferred offer…
Turn Therapeutics Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
TTRX-DEBT
Debt stack $6.1M
90%
Market cache reports total debt of $6.1M.
TTRX-DEBT-20644
Warrants outstanding: 1192207
90%
xbrl warrant detail from xbrl 2026-03-31.
Turn Therapeutics Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Turn Therapeutics Inc..
Turn Therapeutics Inc. Ownership
Holder
Name
Confidence
Evidence
TTRX-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 20 tracked holders.
Turn Therapeutics Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
